HomeNewsBusinessDomestic air passenger traffic in July rose 61% as compared to June: DGCA

Domestic air passenger traffic in July rose 61% as compared to June: DGCA

The total passenger load in July stood at 50.07 lakh, whereas, the number of passengers carried by domestic airlines in June was 31.13 lakh and 19.84 lakh in May.

August 13, 2021 / 19:07 IST
Story continues below Advertisement
Representative image
Representative image

Domestic air passenger traffic surged by 60.84 percent in July as compared to June, the Directorate General of Civil Aviation (DGCA) said on August 13.

The total passenger load in July stood at 50.07 lakh, whereas, the number of passengers carried by domestic airlines in June was 31.13 lakh and 19.84 lakh in May.

Story continues below Advertisement

The passenger traffic in July 2021 also more than doubled when compared to the same month in the past year, the aviation sector regulator said. In July last year, the number of passengers carried by domestic airlines stood at 21.07 lakhs.

Notably, the flight restrictions have been relatively eased as compared to July last year, when complete lockdowns were imposed by several states to curb the pace of COVID-19 transmission. Domestic airlines were allowed to operate at 33 percent capacity utilisation in July 2020 compared to the 65 percent capacity utilisation allowed in July 2021.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show